Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Fovea closes €20.5mm Series A round

Executive Summary

Named after a part of the eye responsible for central, sharper vision, start-up biotech Fovea Pharmaceuticals SA (developing treatments for retinal diseases) received €20.5mm ($25mm) in Series A investments from Sofinnova Partners, Abingworth Management, Wellcome Trust, GIMV, and Credit Agricole Private Equity. Sofinnova, which seeded the company in May 2005, led the round.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies